Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s diseaseChin‐Hsien Lin, Ming‐Shiang Wu, Chieh‐Chang Chen et al.|Journal of Neuroinflammation|2019Cited by 468
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Yu-Jen Fang et al.|The Lancet|2012Cited by 268
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Chieh‐Chang Chen et al.|The Lancet Infectious Diseases|2019Cited by 206
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Yu-Jen Fang et al.|The Lancet|2016Cited by 202
The interplay between <i>Helicobacter pylori</i> and gastrointestinal microbiotaChieh‐Chang Chen, Ming‐Shiang Wu, Jyh‐Ming Liou et al.|Gut Microbes|2021Cited by 198